Mark Oconnor MD in Toledo, Ohio

Medical School: University Of Michigan Medical School
Graduation Year: 1986
The Primary Medical Specialty for Mark Oconnor MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 2466447727
NPI #: 1245232800
NPI Created On: 08/12/2005
NPI Last Updated Listed as: 02/06/2009
Primary Taxonomy Code: 207RC0001X
License Number:
350721050
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Ambetter
• MOLINA HEALTHCARE OF OHIO
• Humana
• CareSource
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Routine ekg using at least 12 leads including interpretation and report
2. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
5. Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
7. Evaluation, testing, and programming adjustment of permanent single lead pacemaker system in one chamber of heart with qualified health care professional analysis, review, and report
8. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
9. Evaluation, testing and programming adjustment of defibrillator with analysis, review and report
10. Evaluation, testing and programming adjustment of defibrillator with analysis, review and report
11. Evaluation, testing and programming adjustment of defibrillator with analysis, review and report
12. Evaluation of parameters of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report
13. Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days
14. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
15. New patient office or other outpatient visit, typically 45 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Initial hospital inpatient care, typically 70 minutes per day
18. Subsequent hospital inpatient care, typically 35 minutes per day
19. Injection, aminophyllin, up to 250 mg
20. Injection, dipyridamole, per 10 mg